Hep-G2/C3A Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | Hep-G2/C3A (often referred to as C3A) is a human (Homo sapiens) cell line established from a liver tumor (hepatoblastoma) of a 15-year-old male patient. It is a clonal subline of the well-known Hep-G2 cell line and therefore originates from malignant hepatic tissue. As a cancer-derived cell line of liver origin, Hep-G2/C3A shows continuous growth in vitro and is widely used as a stable, reproducible model of human liver cells. Owing to its robust growth characteristics and the retention of key liver-specific functions, Hep-G2/C3A is used across multiple research areas. It is particularly common in pharmacology and toxicology as an in vitro model for studying drug metabolism and hepatotoxicity, including 3D spheroid culture formats that can improve the prediction of human liver toxicity. In cancer research, Hep-G2/C3A serves as a model for hepatic tumors (hepatoma/hepatoblastoma) and supports testing of therapeutic strategies under controlled laboratory conditions. Because of its functional similarity to primary hepatocytes (for example, production of plasma proteins and active metabolism), it has also been used in the development of bioartificial liver support systems such as the extracorporeal ELAD device. In addition, Hep-G2/C3A can be permissive to infection by certain human viruses (e.g., Zika virus), making it useful for virology-focused studies in hepatic cell systems. |
|---|---|
| Organism | Human |
| Tissue | Liver |
| Disease | Hepatoblastoma |
| Synonyms | HepG2/C3A, Hep G2/C3A, C3A |
Characteristics
| Age | 15 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | Hep-G2/C3A (Cytion catalog number 305891) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1098 |
Biomolecular Data
| Mutational profile | Mutation: p.Gln61Leu, Heterozygous |
|---|
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305891-071125 | Certificate of Analysis | 11. Dec. 2025 | 305891 |